Ribociclib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ribociclib
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Ribociclib

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

Ribociclib Succinate

Contact Supplier

pharmacompass-2-m-2025-08-25

Ribociclib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 8 USDMF, 2 EU WC, 2 KDMF, 7 NDC API, 19 Listed Suppliers, $ API Reference Price

31 API Suppliers
8 USDMF
2 EU WC
2 KDMF
7 NDC API
19 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

118 Drugs in Development

118 Drugs in Development

INTERMEDIATES

26 Intermediate Suppliers

26 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 3 FDA Orange Book, 3 Europe, 3 Australia, 1 South Africa, 2 Listed Dossiers

12 FDF Dossiers
3 FDA Orange Book
3 Europe
3 Australia
1 South Africa
2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 13 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 7 BASF, 1 CD Formulation, 5 Corel Pharma Chem, 2 DFE Pharma, 9 Gangwal Chemicals, 2 Ideal Cures, 6 Kerry, 1 Keval Exports, 8 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 1 Pluviaendo, 2 Prachin Chemical, 9 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 Silverline Chemicals, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

29 Fillers, Diluents & Binders, 21 Coating Systems & Additives, 17 Disintegrants & Superdisintegrants, 16 Thickeners and Stabilizers, 15 Direct Compression, 12 Lubricants & Glidants, 10 Granulation, 10 Controlled & Modified Release, 7 Co-Processed Excipients, 7 Chewable & Orodispersible Aids, 5 Film Formers & Plasticizers, 5 Solubilizers, 4 Topical, 4 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 3 Taste Masking, 3 Coloring Agents, 2 Parenteral

29 Fillers, Diluents & Binders
21 Coating Systems & Additives
17 Disintegrants & Superdisintegrants
16 Thickeners and Stabilizers
15 Direct Compression
12 Lubricants & Glidants
10 Granulation
10 Controlled & Modified Release
7 Co-Processed Excipients
7 Chewable & Orodispersible Aids
5 Film Formers & Plasticizers
5 Solubilizers
4 Topical
4 Rheology Modifiers
4 Emulsifying Agents
3 API Stability Enhancers
3 Taste Masking
3 Coloring Agents
2 Parenteral

DIGITAL CONTENT

81 News #PharmaBuzz

81 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 3 Regulatory FDF Prices, 8 Annual Reports

2 US Medicaid Prescriptions
3 Regulatory FDF Prices
8 Annual Reports

MARKET PLACE

4 APIs, 3 FDF Dossiers

4 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

42 US Patents, 2 US Exclusivities, 4 Health Canada Patents

42 US Patents
2 US Exclusivities
4 Health Canada Patents

$ API Ref.Price (USD/KG) : 15,654 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Gowling WLG (Canada) LLP

filter Patent Reset all filters

4 All

01 12652044

02 12734802

03 12815839

04 12918190

filter Product Reset all filters

4 All

01 4RIBOCICLIB SUCCINATE

filter Dosage Reset all filters

4 All

01 4TABLET

filter Exp Date Reset all filters

4 All

01 12027-05-24

02 12029-08-20

03 12031-11-09

04 12034-08-07

Egis Ribociclib

Product Main Page

01

Gowling WLG (Canada) LLP

Ribociclib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-08-20

Date Granted : 2019-03-05

Brand Name : KISQALI

Patent Number : 2734802

Filing Date : 2009-08-20

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-08-20

Date Granted : 2019-03-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

Ribociclib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-05-24

Date Granted : 2016-01-12

Brand Name : KISQALI

Patent Number : 2652044

Filing Date : 2007-05-24

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-05-24

Date Granted : 2016-01-12

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

Ribociclib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-11-09

Date Granted : 2019-08-06

Brand Name : KISQALI

Patent Number : 2815839

Filing Date : 2011-11-09

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-11-09

Date Granted : 2019-08-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

Ribociclib

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-08-07

Date Granted : 2023-01-17

Brand Name : KISQALI

Patent Number : 2918190

Filing Date : 2014-08-07

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2034-08-07

Date Granted : 2023-01-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!